Forest Laboratories Inc. (Active Pharmaceutical Ingredient Watch).(Brief Article)

Chemical Market Reporter, March, 2002

FOREST Laboratories Inc.'s licensor, Lipha SA, a subsidiary of Merck KGaA, has been granted priority review with FDA for its new drug application for acamprosate, a drug to treat alcohol addition. The drug is marketed by Merck in Europe as Campral. Forest acquired US rights from Merck in 2001.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement